This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
The inspection classification was determined by the agency as Voluntary Action Indicated
The cognitively operated system is a mother patent invention, first launched in India
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Sets price band at ?695 to ?735 per Equity Share
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Subscribe To Our Newsletter & Stay Updated
